marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-22-2023
Nabriva Therapeutics plc Financial Ratios 2011-2024 | NBRV
Annual Financial Ratios Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.0 | -0.0 | -12.6 | -8.5 | -26.6 | -3.2 | -5.7 | - | - | - | - |
P/S |
0.1 | 0.0 | 0.2 | 134.1 | 149.3 | - | - | - | - | - | - | - |
EPS |
-21.3 | -28.5 | -135.2 | -11.2 | -2.3 | -2.5 | -25.6 | -48.0 | -44.4 | - | - | - |
EV (Enterprise Value) |
20.2 M | -19.3 M | -15.1 M | 1.01 B | 910 M | 1.91 B | 159 M | 152 M | 39.3 M | 30.6 M | - | - |
EBITDA per Share |
-20.6 | -27.8 | -128 | -1.06 | -2.24 | -2.46 | -25.3 | -11 | - | - | - | - |
EV/EBITDA |
0.4 | -5.3 | -12.5 | -7.8 | -25.8 | -2.6 | -6.1 | - | - | - | - | |
PEG |
-0.0 | -0.0 | -0.0 | -0.25 | -0.92 | -0.3 | -0.23 | 0.03 | - | - | - | - |
P/B |
1.2 | 0.0 | 0.0 | 25.2 | 14.1 | 24.1 | 2.3 | 1.6 | - | - | - | - |
P/CF |
-0.1 | -0.0 | -0.0 | -14.4 | -13.3 | -28.1 | -3.5 | -8.2 | - | - | - | - |
ROE % |
-1736.56 | -92.69 | -209.70 | -200.52 | -167.24 | -90.60 | -71.05 | -28.85 | - | - | - | - |
ROA % |
-180.03 | -61.12 | -118.91 | -87.94 | -103.95 | -77.65 | -58.87 | -26.55 | - | - | - | - |
ROCE % |
-1333.89 | -82.86 | -165.68 | -102.60 | -123.50 | -89.41 | -71.15 | -24.65 | - | - | - | - |
Current Ratio |
1.1 | 2.9 | 2.3 | 5.5 | 6.1 | 7.1 | 5.7 | 12.5 | - | - | - | - |
DSO |
59.2 | 80.1 | 241.5 | 129.3 | 301.6 | - | - | - | - | - | - | - |
DIO |
154.4 | 282.2 | 1549.8 | 3556.1 | - | - | - | - | - | - | - | - |
DPO |
62.6 | 100.8 | 1801.7 | 24366.4 | - | - | - | - | - | - | - | - |
Operating Cycle |
213.7 | 362.4 | 1791.3 | 3685.4 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
151.1 | 261.6 | -10.3 | -20680.9 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Nabriva Therapeutics plc
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.72 | - | -4.21 | - | -5.03 | - | -5.27 | -0.29 | -0.53 | - | -0.9 | -1.37 | -2.46 | -0.29 | -0.24 | -0.3 | -0.29 | -0.46 | -0.9 | -0.44 | -0.36 | -0.61 | -0.79 | -0.54 | -5.6 | -6.84 | -6.58 | -0.57 | -6.42 | -3.79 | -7.46 | -37.54 | -30.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-2.64 | - | -4.03 | - | -4.88 | - | -5.22 | -0.28 | -0.51 | - | -0.89 | -1.26 | -2.12 | -2.33 | -0.23 | -0.29 | -0.28 | -0.46 | -0.9 | -0.43 | -0.34 | -0.61 | -0.73 | -0.57 | -5.56 | -5.42 | -0.65 | -0.54 | -6.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
77.81 | -103.42 | -120.25 | -92.15 | -77.13 | -59.24 | -98.33 | -120.58 | -150.20 | -155.88 | -211.71 | -215.74 | -221.74 | -200.52 | -189.60 | -223.46 | -196.79 | -167.24 | -149.46 | -99.62 | -91.49 | -90.60 | -83.13 | -74.12 | -72.00 | -71.05 | -58.72 | -40.60 | -24.93 | -7.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-101.45 | -59.80 | -71.76 | -41.87 | -54.19 | -41.88 | -64.04 | -74.25 | -88.36 | -88.39 | -112.88 | -109.62 | -106.26 | -87.94 | -91.37 | -120.30 | -113.35 | -103.95 | -99.28 | -74.69 | -73.83 | -77.65 | -70.69 | -62.45 | -60.18 | -58.87 | -49.35 | -34.33 | -21.35 | -6.77 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
123.99 | -88.80 | -104.39 | -54.51 | -69.45 | -52.53 | -85.64 | -103.17 | -124.45 | -119.91 | -148.40 | -137.48 | -128.34 | -102.60 | -107.46 | -142.40 | -134.45 | -123.50 | -117.16 | -85.14 | -84.88 | -89.41 | -81.46 | -74.54 | -70.57 | -71.15 | -61.52 | -43.32 | -28.42 | -9.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.1 | 2.1 | - | 3.1 | 2.9 | 3.5 | 3.6 | 3.2 | 2.3 | 2.3 | 2.3 | 2.3 | 1.8 | 1.8 | 1.8 | 1.8 | 2.6 | 2.6 | 2.6 | 2.6 | 7.0 | 7.0 | 7.0 | 7.0 | 5.8 | 5.8 | 5.8 | 5.8 | 13.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
103.7 | - | 61.8 | - | 135.2 | - | 137.0 | 87.3 | 76.9 | - | 276.3 | 732.4 | 384.7 | 751.9 | 36.2 | 476.9 | 177.2 | 443.2 | 383.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
192.3 | - | 179.1 | - | 409.2 | - | 279.2 | 240.5 | 10888.9 | - | 21254.0 | 1443.9 | 37098.8 | - | 4148.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
127.6 | - | 40.2 | - | 80.8 | - | 33.2 | 65.8 | 4801.7 | - | 10544.9 | 716.4 | 43127.0 | - | 28427.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
296.0 | - | 240.8 | - | 544.3 | - | 416.2 | 327.9 | 10965.8 | - | 21530.2 | 2176.3 | 37483.6 | 751.9 | 4185.0 | 476.9 | 177.2 | 443.2 | 383.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
168.4 | - | 200.6 | - | 463.6 | - | 382.9 | 262.1 | 6164.1 | - | 10985.4 | 1460.0 | -5643.5 | 751.9 | -24242.4 | 476.9 | 177.2 | 443.2 | 383.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency